5-Bromo-1H-indazol-3-amine

Catalog No. :
ACGOTX185
CAS No. :
61272-71-7
Molecular Formula :
C7H6BrN3
Molecular Weight :
212.05

IUPAC Name:5-bromo-1H-indazol-3-amine

5-Bromo-1H-indazol-3-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$60.00Login to see priceIn stockInquiry
100g97%$240.00Login to see priceIn stockInquiry
500g97%$1200.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-1H-indazol-3-amine
IUPAC Name5-bromo-1H-indazol-3-amine
MDL No.MFCD03426696
Molecular FormulaC7H6BrN3
Molecular Weight212.05
SMILESNC1=NNC2=C1C=C(Br)C=C2
InChI KeyOMPYFDJVSAMSMA-UHFFFAOYSA-N
SynonymBDBM50254986 | 3-Amino-5-bromoindazole | 3-Amino-5-bromo-indazole | PB20824 | EN300-223999 | Z1203159770 | 5-Bromo-2H-indazol-3-amine | A15690 | BBL104250 | OMPYFDJVSAMSMA-UHFFFAOYSA-N | STK501613 | Q27455606 | SCHEMBL786329 | J-516795 | SY007052 | 10Y-07
CAS No.61272-71-7
PubChem CID817910

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACGOTX185 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTPOY204 route compound structure diagram
    ACTPOY204179897-89-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGOTX185 route product structure diagram
    ACGOTX18561272-71-7 In Stock
Inquiry

2. ACGOTX185 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTPOY204 route compound structure diagram
    ACTPOY204179897-89-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7 In Stock
  6. Then
  7. ACGOTX185 route product structure diagram
    ACGOTX18561272-71-7 In Stock
Inquiry

Comments (0)